Cargando…
Metabolomic profiling of triple negative breast cancer cells suggests that valproic acid can enhance the anticancer effect of cisplatin
Cisplatin is an effective chemotherapeutic agent for treating triple negative breast cancer (TNBC). Nevertheless, cisplatin-resistance might develop during the course of treatment, allegedly by metabolic reprograming, which might influence epigenetic regulation. We hypothesized that the histone deac...
Autores principales: | Granit, Avital, Mishra, Kumudesh, Barasch, Dinorah, Peretz-Yablonsky, Tamar, Eyal, Sara, Kakhlon, Or |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9760697/ https://www.ncbi.nlm.nih.gov/pubmed/36544904 http://dx.doi.org/10.3389/fcell.2022.1014798 |
Ejemplares similares
-
Valproic acid reprograms the metabolic aberration of cisplatin treatment via ALDH modulation in triple-negative breast cancer cells
por: Granit Mizrahi, Avital, et al.
Publicado: (2023) -
Multifaceted Analyses of Isolated Mitochondria Establish the Anticancer Drug 2-Hydroxyoleic Acid as an Inhibitor of Substrate Oxidation and an Activator of Complex IV-Dependent State 3 Respiration
por: Mishra, Kumudesh, et al.
Publicado: (2022) -
Valproic Acid Synergizes With Cisplatin and Cetuximab in vitro and in vivo in Head and Neck Cancer by Targeting the Mechanisms of Resistance
por: Iannelli, Federica, et al.
Publicado: (2020) -
The Beneficial Effect of Mitochondrial Transfer Therapy in 5XFAD Mice via Liver–Serum–Brain Response
por: Sweetat, Sahar, et al.
Publicado: (2023) -
Lacosamide at therapeutic concentrations induces histone hyperacetylation in vitro
por: Granit, Avital, et al.
Publicado: (2018)